Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Volume: 5, Issue: 5, Pages: 441 - 453
Published: Feb 21, 2020
Paper Details
Title
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Published Date
Feb 21, 2020
Volume
5
Issue
5
Pages
441 - 453
Notes
History